Literature DB >> 20630665

Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery.

ChinLoon Ong1, Wilko F A R Verbakel, Johan P Cuijpers, Ben J Slotman, Suresh Senan.   

Abstract

PURPOSE: Volumetric modulated arc therapy (RapidArc; Varian Medical Systems, Palo Alto, CA) allows fast delivery of stereotactic radiotherapy for Stage I lung tumors. We investigated discrepancies between the calculated and delivered dose distributions, as well as the dosimetric impact of leaf interplay with breathing-induced tumor motion. METHODS AND MATERIALS: In 20 consecutive patients with Stage I lung cancer who completed RapidArc delivery, 15 had tumor motion exceeding 5 mm on four-dimensional computed tomography scan. Static and dynamic measurements were performed with Gafchromic EBT film (International Specialty Products Inc., Wayne, NJ) in a Quasar motion phantom (Modus Medical Devices, London, Ontario, Canada). Static measurements were compared with calculated dose distributions, and dynamic measurements were compared with the convolution of static measurements with sinusoidal motion patterns. Besides clinical treatment plans, additional cases were optimized to create excessive multileaf collimator modulation and delivered on the phantom with peak-to-peak motions of up to 25 mm. γ Analysis with a 3% dose difference and 2- or 1-mm distance to agreement was used to evaluate the accuracy of delivery and the dosimetric impact of the interplay effect.
RESULTS: In static mode film dosimetry of the two-arc delivery in the phantom showed that, on average, fewer than 3% of measurements had γ greater than 1. Dynamic measurements of clinical plans showed a high degree of agreement with the convolutions: for double-arc plans, 99.5% met the γ criterion. The degree of agreement was 98.5% for the plans with excessive multileaf collimator modulations and 25 mm of motion.
CONCLUSIONS: Film dosimetry shows that RapidArc accurately delivers the calculated dose distribution and that interplay between leaves and tumor motion is not significant for single-fraction treatments when RapidArc is delivered with two different arcs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20630665     DOI: 10.1016/j.ijrobp.2010.02.059

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  34 in total

1.  RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.

Authors:  J M Park; K Kim; E K Chie; C H Choi; S J Ye; S W Ha
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

2.  Interplay effect modeling in stereotactic body radiotherapy treatment of liver cancer using volumetric modulated arc therapy.

Authors:  Deepak Thaper; Arun S Oinam; Rose Kamal; Gaganpreet Singh; Bhumika Handa; Vivek Kumar; Hanuman P Yadav
Journal:  Phys Eng Sci Med       Date:  2021-02-04

3.  FusionArc optimization: a hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy.

Authors:  Martha M Matuszak; Jennifer M Steers; Troy Long; Daniel L McShan; Benedick A Fraass; H Edwin Romeijn; Randall K Ten Haken
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

4.  4D radiobiological modelling of the interplay effect in conventionally and hypofractionated lung tumour IMRT.

Authors:  J Selvaraj; J Uzan; C Baker; A Nahum
Journal:  Br J Radiol       Date:  2014-09-24       Impact factor: 3.039

5.  Accuracy of Breath-hold CT in Treatment Planning for Lung Stereotactic Ablative Radiotherapy.

Authors:  Dominique Mathieu; Charles Martel; Marie-Pierre Campeau; Édith Filion; David Roberge; Houda Bahig; Toni Vu; Louise Lambert; Karim Boudam; Jean-Francois Carrier
Journal:  Cureus       Date:  2014-12-22

6.  Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy.

Authors:  Tobias Gauer; Thilo Sothmann; Oliver Blanck; Cordula Petersen; René Werner
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

7.  Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Authors:  Ben J Slotman
Journal:  J Radiosurg SBRT       Date:  2011

8.  Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters.

Authors:  S Dowdell; C Grassberger; G C Sharp; H Paganetti
Journal:  Phys Med Biol       Date:  2013-05-20       Impact factor: 3.609

Review 9.  Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Authors:  Nikhil Yegya-Raman; Wei Zou; Ke Nie; Jyoti Malhotra; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

10.  Off-target-isocentric approach in non-coplanar Volumetric Modulated Arc Therapy (VMAT) planning for lung SBRT treatments.

Authors:  Sangroh Kim; Tzu-Chi Tseng
Journal:  J Radiosurg SBRT       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.